Conceptio
›
Archive
›
ClinicalTrials.gov
ClinicalTrials.gov
public full text
Phase 1b/2 Trial of Ipilimumab, Nivolumab, and Ciforadenant (Adenosine A2a Receptor Antagonist) in First-line Advanced Renal Cell Carcinoma.
M.D. Anderson Cancer Center
· 2023
ClinicalTrials.gov · Datasets · License: Public Domain · 2023
Open Source ↗
renal-cell-carcinoma
renal cell carcinoma, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Imaging Procedure Using ALA in Finding Residual Tumor in Grade IV Malignant Astrocytoma
#1033716
Infusional Carfilzomib in Patients With Relapsed or Refractory Multiple Myeloma
#1033723
The Effect of Nicorandil on Rheumatoid Arthritis Patients
#1033725
Acupuncture for Heel Pain Syndrome
#1033717
A Study to Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids
#1033719
Record
· ID 918325
Retrieved via
Conceptio
— every document is proof-bundled with source, license, and retrieval metadata.